Anticoagulation for atrial fibrillation detected by device

+Practice
In print
Heartbeat

Anticoagulation for atrial fibrillation detected by device

Chris Ellis

Chris Ellis

Heartbeat ECG
[Image: Supplied]

Consultant cardiologist Chris Ellis looks at the management of short runs of atrial fibrillation detected by pacemaker

Key points, The management of device-detected short runs of atrial fibrillation is an increasing clinical dilemma, and clinical trials are trying to guide correct, Pract Green w Pale Yellow
References

1. Healey JS, Lopes RD, Granger CB, et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med 2024;390(2):107–17.

2. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009;2(5):474–80.

3. Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of devicedetected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 2017;38(17):1339–44.